View
Page
Well I agree on wether such à large portioneren op R&D should be capitalized, because if you add those to opex the ebitda would schrink to marginal levels and might be even negative....therefore the fcf when these capitalized costs are included is only marginally positive. But this is inherent to the business and industry and allowed them to grow so fast....also these capitalized costs were no issue when the stock went up towards 350p at the beginning of the year!!! So this stinks....either some shorters are collaborating with each other and with brokers like cannacord......manipulation....which can be seen when looking at price action and blocks traded! But why is this not reported to the fca or whatever????
Latest from the Community...
Latest from the Community...
Latest from the Community...
